Nhlbi, hematology consults service requires a ttas-01 device including reagents and consumables in order to evaluate the strength of primary hemostatic response

Ended Purchase Order Awarded Last action

Contract number
75N92021P00082
Awardee
Awarding agency
Obligated
$18,246

Award facts

Contract value 100% obligated
$18,246.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334510 Electromedical and Electrotherapeutic Apparatus Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Liberty Township, OH 45069, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The National Heart Lung and Blood Institute awarded a purchase order to Diapharma Consulting, Inc. for $18,246 on March 3, 2021, to supply a TTAS-01 device including reagents and consumables for hematology consults service. The device evaluates the strength of primary hemostatic response generated by platelets as a marker of individual blood coagulation components. Performance is located in Liberty Township, Ohio. The order carries firm fixed price terms with an ultimate completion date of April 5, 2021.

Quick answers

Who was awarded contract 75N92021P00082?

75N92021P00082 was awarded to Diapharma Consulting, Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on March 3, 2021.

How much is contract 75N92021P00082 worth?

The government has obligated $18,246 on 75N92021P00082.

Was contract 75N92021P00082 competed?

The extent of competition for 75N92021P00082 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login